Tempus Ai Cl A (TEM)

$57.82 +0.94 (1.65%)
Market Cap 9.85B
Revenue (ttm) 693.40M
Net Income (ttm) -705.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -101.79%
Debt to Equity Ratio 1.74
Volume 7,104,600
Avg Vol 13,490,102
Day's Range N/A - N/A
Shares Out 173.12M
Stochastic %K 20%
Beta N/A
Analysts Sell
Price Target $66.70

Company Profile

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services...

Industry: Health Information Services
Sector: Healthcare
Phone: 800 976 5448
Fax: 800 893 0276
Address:
600 West Chicago Avenue, Suite 510, Chicago, United States
trading__analysis
trading__analysis Jul. 15 at 8:42 AM
Planning on cutting $TEM soon if it doesn't get a bounce here, this one has been lagging a lot recently and losing its momentum so leaning bearish on this one. Might end up cutting this tmrw.
0 · Reply
hussain105
hussain105 Jul. 14 at 11:55 PM
$TEM Add some today Will add more at 54
0 · Reply
Elevate1
Elevate1 Jul. 14 at 9:11 PM
$TEM
0 · Reply
winiek
winiek Jul. 14 at 8:44 PM
$TEM I keep shorting. 2950 shares short at 60. Will cover at 50
0 · Reply
Zhezha
Zhezha Jul. 14 at 8:29 PM
$TEM who is dumping at the end ?
1 · Reply
Olddrache
Olddrache Jul. 14 at 7:40 PM
$TEM more chop
2 · Reply
m_23nyc
m_23nyc Jul. 14 at 7:37 PM
$TEM going to wake up to GS PT over $100 one day soon
0 · Reply
VectorVictor
VectorVictor Jul. 14 at 7:19 PM
$TEM Come on let’s strap on those big girl panties and roll!
0 · Reply
RobotMumba100
RobotMumba100 Jul. 14 at 7:15 PM
$TEM and if tempus is going to make a deal with $PLTR ? why not? $AZN $BNTX $PFE
0 · Reply
Justadudetrying
Justadudetrying Jul. 14 at 6:40 PM
" $OSCR is one of the most undervalued stocks in the market. Healthcare stocks are struggling, no doubt about that. But tech > healthcare will likely happen in the second half of 2025. $UNH, $OSCR, $HIMS, and $TEM will be among the winners of the coming tech pullback." "Opportunity doesn't come often—so seize it when it comes." Charlie Munger
0 · Reply
Latest News on TEM
Apple Acquisition Buzz: Its $60 Billion War Chest Is Enough To Buy Datadog And Tempus

Jul 10, 2025, 12:15 PM EDT - 4 days ago

Apple Acquisition Buzz: Its $60 Billion War Chest Is Enough To Buy Datadog And Tempus

AAPL DDOG

Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients

Jul 9, 2025, 4:00 PM EDT - 5 days ago

Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients

PSNL

Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer

Jul 8, 2025, 8:30 AM EDT - 6 days ago

Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer

Tempus AI: High-Growth And High-Risk

Jul 1, 2025, 2:48 PM EDT - 13 days ago

Tempus AI: High-Growth And High-Risk

Tempus Announces Pricing of Upsized Offering of $650 Million of Convertible Senior Notes

Jun 30, 2025, 10:43 PM EDT - 14 days ago

Tempus Announces Pricing of Upsized Offering of $650 Million of Convertible Senior Notes

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

Jun 30, 2025, 7:00 AM EDT - 14 days ago

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

Ambry Genetics' CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing

Jun 25, 2025, 5:00 PM EDT - 19 days ago

Ambry Genetics' CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing

Tempus AI Is Well Worth Its Price Tag

Jun 25, 2025, 8:07 AM EDT - 19 days ago

Tempus AI Is Well Worth Its Price Tag

TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm

Jun 23, 2025, 11:42 AM EDT - 21 days ago

TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm

Tempus to Participate in TD Cowen's 4th Annual Tools/Dx Revolution Conference

Jun 17, 2025, 8:30 AM EDT - 27 days ago

Tempus to Participate in TD Cowen's 4th Annual Tools/Dx Revolution Conference

Shamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tempus AI, Inc. and Sets a Lead Plaintiff Deadline of August 12, 2025

Jun 13, 2025, 3:00 PM EDT - 4 weeks ago

Shamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tempus AI, Inc. and Sets a Lead Plaintiff Deadline of August 12, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Shareholders to Learn More About the Investigation

Jun 12, 2025, 10:00 AM EDT - 4 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Shareholders to Learn More About the Investigation

Tempus Announces Collaboration with Northwestern University's Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer's Disease Research

Jun 12, 2025, 8:30 AM EDT - 4 weeks ago

Tempus Announces Collaboration with Northwestern University's Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer's Disease Research

Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 11, 2025, 10:00 AM EDT - 4 weeks ago

Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Tempus AI, Inc. (TEM) Shareholders to Inquire about Securities Investigation

Jun 10, 2025, 10:00 AM EDT - 4 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Tempus AI, Inc. (TEM) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Tempus AI, Inc. (TEM) And Encourages Shareholders to Connect

Jun 9, 2025, 10:00 AM EDT - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Tempus AI, Inc. (TEM) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Tempus AI, Inc. (TEM) Stockholders to Inquire about Securities Investigation

Jun 8, 2025, 10:00 AM EDT - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Tempus AI, Inc. (TEM) Stockholders to Inquire about Securities Investigation

I'm Still Bullish On Tempus AI

Jun 7, 2025, 10:06 AM EDT - 5 weeks ago

I'm Still Bullish On Tempus AI

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Investors to Learn More About the Investigation

Jun 6, 2025, 10:00 AM EDT - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Investors to Learn More About the Investigation

Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 5, 2025, 10:00 AM EDT - 5 weeks ago

Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Tempus AI, Inc. (TEM) And Encourages Investors to Connect

Jun 4, 2025, 10:00 AM EDT - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Tempus AI, Inc. (TEM) And Encourages Investors to Connect

Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 2, 2025, 10:00 AM EDT - 6 weeks ago

Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers

Jun 2, 2025, 8:30 AM EDT - 6 weeks ago

Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Stockholders to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Stockholders to Learn More About the Investigation

Introducing Tempus One in the EHR with Integrated Guidelines

Jun 1, 2025, 8:30 AM EDT - 6 weeks ago

Introducing Tempus One in the EHR with Integrated Guidelines

Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model

May 31, 2025, 8:30 AM EDT - 6 weeks ago

Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model

Bronstein, Gewirtz & Grossman, LLC Encourages Tempus AI, Inc. (TEM) Investors to Inquire about Securities Investigation

May 30, 2025, 10:00 AM EDT - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Tempus AI, Inc. (TEM) Investors to Inquire about Securities Investigation

Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting

May 30, 2025, 8:30 AM EDT - 6 weeks ago

Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting

trading__analysis
trading__analysis Jul. 15 at 8:42 AM
Planning on cutting $TEM soon if it doesn't get a bounce here, this one has been lagging a lot recently and losing its momentum so leaning bearish on this one. Might end up cutting this tmrw.
0 · Reply
hussain105
hussain105 Jul. 14 at 11:55 PM
$TEM Add some today Will add more at 54
0 · Reply
Elevate1
Elevate1 Jul. 14 at 9:11 PM
$TEM
0 · Reply
winiek
winiek Jul. 14 at 8:44 PM
$TEM I keep shorting. 2950 shares short at 60. Will cover at 50
0 · Reply
Zhezha
Zhezha Jul. 14 at 8:29 PM
$TEM who is dumping at the end ?
1 · Reply
Olddrache
Olddrache Jul. 14 at 7:40 PM
$TEM more chop
2 · Reply
m_23nyc
m_23nyc Jul. 14 at 7:37 PM
$TEM going to wake up to GS PT over $100 one day soon
0 · Reply
VectorVictor
VectorVictor Jul. 14 at 7:19 PM
$TEM Come on let’s strap on those big girl panties and roll!
0 · Reply
RobotMumba100
RobotMumba100 Jul. 14 at 7:15 PM
$TEM and if tempus is going to make a deal with $PLTR ? why not? $AZN $BNTX $PFE
0 · Reply
Justadudetrying
Justadudetrying Jul. 14 at 6:40 PM
" $OSCR is one of the most undervalued stocks in the market. Healthcare stocks are struggling, no doubt about that. But tech > healthcare will likely happen in the second half of 2025. $UNH, $OSCR, $HIMS, and $TEM will be among the winners of the coming tech pullback." "Opportunity doesn't come often—so seize it when it comes." Charlie Munger
0 · Reply
eagles827
eagles827 Jul. 14 at 5:32 PM
$TEM stay above $58 for the rest of the week please. I want the puts I sold to stay worthless please.
0 · Reply
koditrump
koditrump Jul. 14 at 5:24 PM
$TEM $60 is tough
0 · Reply
theoptionsplug
theoptionsplug Jul. 14 at 5:05 PM
4 Days Ago: Jim Cramer was asked about Tempus AI $TEM stock ... "Another company that's just losing money hand over fist. I just can't go there." $TEM is up nearly 5% since.
0 · Reply
ScreamLikeABaby
ScreamLikeABaby Jul. 14 at 4:19 PM
$TEM https://finance.yahoo.com/news/tempus-ai-expands-tempus-next-151153997.html
0 · Reply
upsidetrader
upsidetrader Jul. 14 at 3:30 PM
$TEM about 8 days now bouncing along the 100-DMA, needs more work but maybe trying to find its legs
0 · Reply
Ryanmac8688
Ryanmac8688 Jul. 14 at 3:09 PM
$TEM loading
0 · Reply
Ryanmac8688
Ryanmac8688 Jul. 14 at 3:08 PM
$TEM
0 · Reply
ScreamLikeABaby
ScreamLikeABaby Jul. 14 at 2:49 PM
$TEM Latest News.. Guggenheim boosted their price target to $75.00 from $65.00 on June 30, 2025, maintaining a "Buy" rating. Bank of America reiterated a "Neutral" rating and raised their price target to $70.00 from $68.00 on June 25, 2025. Cathie Wood loaded up on Tempus AI last week
0 · Reply
koditrump
koditrump Jul. 14 at 1:42 PM
$TEM Thank god!!
0 · Reply
fuzzy_kumo
fuzzy_kumo Jul. 14 at 1:41 PM
$TEM wut news?
0 · Reply
Elevate1
Elevate1 Jul. 14 at 12:35 PM
$TEM
0 · Reply
Elevate1
Elevate1 Jul. 14 at 12:35 PM
$TEM
0 · Reply